Pasithea Therapeutics Corporation

We are at the forefront of research focusing on development of therapies for diseases of the central nervous system (CNS).

With an experienced team of experts in the fields of neuroscience and pharmacology, Pasithea is developing new molecular entities for the treatment of CNS disorders, including Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis, Neurofibromatosis type 1 and Noonan syndrome.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Lincoln Road 1111
Miami Beach 33139 FL US
Get directions